ResMed Inc. (
F2Q2012 (Qtr End 12/31/2011) Earnings Call
January 26, 2012 04:30 pm ET
Peter Farrell - Founder, Chairman, and CEO
Brett Sandercock - CFO
Rob Douglas - COO
Don Darkin - President, SDB Strategic Business Unit
Geoff Neilson - President, Respiratory Care Strategic Business Unit
Mick Farrell – President, Americas
Ben Andrew - William Blair
Michael Matson - Mizuho Securities
Joanne Wuensch - BMO Capital Markets
Jason Mills - Canaccord
Matthew Prior - Bank of America Merrill Lynch
David Clair - Piper Jaffray
Dan Hurren - UBS
David Low - Deutsche Bank
Good day ladies and gentlemen and welcome to the second quarter 2012 ResMed Inc earnings conference call. My name is Stacy and I will be your conference moderator for today. At this time all participants are in a listen-only mode. We will conduct a question-and-answer session towards the end of the conference. (Operator Instructions) As a reminder, this conference call is being recorded for replay purposes.
In addition the company asks me to address certain matters. First, ResMed does not authorize the recording of any portion of this conference call for any purpose. Second, during the conference call, ResMed may make forward-looking statements such as projections of future revenue or earnings, new product development or new markets of the company’s products. These statements are made under the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995.
Risks and uncertainties exist that could cause actual results to materially differ from the forward-looking statements. These factors are discussed in ResMed’s SEC filings such as Forms 10-Q and 10-K, which you may access through the company’s website at www.resmed.com.